BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2419257)

  • 1. In vivo reduction of circulating C1q binding immune complexes by intravenous gammaglobulin administration.
    Lin RY; Racis SP
    Int Arch Allergy Appl Immunol; 1986; 79(3):286-90. PubMed ID: 2419257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The IgG detected in the C1q solid-phase immune-complex assay is not always of immune-complex nature.
    Hack CE; Belmer AJ
    Clin Immunol Immunopathol; 1986 Jan; 38(1):120-8. PubMed ID: 3484437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of C1q-binding IgG complexes in systemic lupus erythematosus.
    Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K
    Clin Immunol Immunopathol; 1984 Jan; 30(1):104-16. PubMed ID: 6421520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.
    Nydegger UE; Lambert PH; Gerber H; Miescher PA
    J Clin Invest; 1974 Aug; 54(2):297-309. PubMed ID: 4847246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C1q binding and C1q deviation assays using enzyme labelled C1q.
    Smith GW; Myles MJ; Simpson IJ
    J Immunol Methods; 1984 Feb; 67(1):167-72. PubMed ID: 6366065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Demonstration of circulating immune complexes using a C1q-solid phase enzyme immunoassay].
    Schössler W; Hiepe F; Courault K; Porstmann B; Apostoloff E
    Biomed Biochim Acta; 1983; 42(7-8):1027-35. PubMed ID: 6360166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
    Antes U; Heinz HP; Loos M
    J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An enzyme-linked immunoassay for detection of IgG- and C3-containing circulating immune complexes: comparison with a radioimmunoassay and quantitation in patients with rheumatic diseases.
    Panush RS; Somberg LB; Katz P; Longley S
    Diagn Immunol; 1983; 1(4):288-94. PubMed ID: 6388973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of circulating immune complexes and of their component immunoglobulin classes M, G, and A with a C1q-ELISA].
    Sequeira Peña GA; Herrmann D; Vogt KH; Jäger L
    Allerg Immunol (Leipz); 1991; 37(1):37-45. PubMed ID: 2063729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous gammaglobulin therapy in idiopathic thrombocytopenic purpura. Results with the Netherlands Red Cross immunoglobulin preparation.
    Vos JJ; van Aken WG; Engelfriet CP; von dem Borne AE
    Vox Sang; 1985; 49(2):92-100. PubMed ID: 2412349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of solid-phase Clq-ELISA for detecting circulating immune complexes in human diseases].
    Aleshkin VA; Nasonov EL; Eremeeva MV; Kobylianskiĭ AG
    Ter Arkh; 1989; 61(6):113-6. PubMed ID: 2477907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating C1q binding immune complexes in relatives of patients with systemic lupus erythematosus.
    Elkon KB; Walport MJ; Rynes RI; Black CM; Batchelor JR; Hughes GR
    Arthritis Rheum; 1983 Jul; 26(7):921-4. PubMed ID: 6603223
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship between renal pathology and the size of circulating immune complexes in patients with systemic lupus erythematosus.
    Wener MH; Mannik M; Schwartz MM; Lewis EJ
    Medicine (Baltimore); 1987 Mar; 66(2):85-97. PubMed ID: 3102894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of circulating immune complexes by a C1q-microplate ELISA system.
    Singh VK; Tingle AJ
    J Immunol Methods; 1982; 50(1):109-14. PubMed ID: 6177790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of complement components C1q, C3, C4 and C5 to a model immune complex in ELISA.
    Larsson A; Sjöquist J
    J Immunol Methods; 1989 Apr; 119(1):103-9. PubMed ID: 2785142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating immune complex-like materials which bind to heat inactivated C1q interfere with the C1q solid phase assay for immune complexes.
    Fukuda K; Seino J; Kinoshita Y; Sudo K; Horigome I; Saito T; Furuyama T; Yoshinaga K
    Tohoku J Exp Med; 1985 Aug; 146(4):449-56. PubMed ID: 3907015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune complexes in SLE.
    Inman RD
    Clin Rheum Dis; 1982 Apr; 8(1):49-62. PubMed ID: 6214365
    [No Abstract]   [Full Text] [Related]  

  • 18. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
    Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
    J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid phase C1q microassay for the rapid detection of circulating immune complexes.
    Orozco A; Contreras CE; Sánchez P; Meilijson O; Bianco NE
    J Immunol Methods; 1983 Apr; 59(2):237-43. PubMed ID: 6341470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Porcine C1q and the solid-phase immunoassay of human immune complexes.
    Ziola B; Salmi A; Penttinen K
    J Immunol Methods; 1982 Mar; 49(3):247-60. PubMed ID: 6978362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.